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PPROM on hospital day 12.’ The only word I understood 
was ‘methamphetamine,’ and I was petrified. I envisioned 
a large billboard back home in San Francisco that featured 
an emaciated woman, eyes glistening with psychosis, with 
only a lone tooth, depicting, hyperbolically, the disastrous 
effects of methamphetamine on the body.
The next morning I steeled myself for my first meeting 
with such a methamphetamine user. After reviewing Ms. 
Valle’s chart, I knocked, entered her room, and was taken 
aback. Here was a startlingly healthy woman. She had all 
of her teeth. She wasn’t emaciated. Disarmed, I stumbled 
through my questions—questions I’d prepared for a more 
hostile recipient. Lisa answered my questions calmly and 
asked important and pertinent questions about her baby’s 
health. As I went over her baby’s prognosis and the likely 
length of her hospital stay (not cheerful answers on either 
account) her demeanour paradoxically brightened a bit. She 
promised to think of more questions for me.
I learned more about her over the following week, includ-
ing her ‘substance abuse history.’ She’d tried meth once years 
ago, a poor decision borne from late-night alcohol-fuelled 
peer pressure. When I first started my presentations in front 
of the entire team, I emulated my resident, pronouncing my 
patient’s drug history in my opening line. But eventually her 
methamphetamine use sank down through my presentation, 
until finally I didn’t mention it at all. It was a remote history 
written on the board, and even this seemed unjust.
Lisa’s drug history was a profound piece of health infor-
mation for me. It was a perplexing thing; the word ‘meth-
amphetamine’ scared me, but also set my mind whirring. If 
methamphetamines directly caused her condition, my cog-
nitive response to her drug history could have been vital. 
But the relevance of remote, one-time drug use was more 
murky. The billboard’s emaciated, toothless spectre arose 
with little benefit to Lisa’s care.
Abstract Illicit drug use, and the associated health prob-
lems, is a frequent issue encountered by medical providers. 
Because of its salience as a piece of health care informa-
tion, drug use history is often included in patient charts and 
presentations by house staff and medical students. How-
ever, if used and recorded inappropriately, drug use history 
can have significant long-lasting effects on the perception 
of patients in a system where they have little agency.
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It was my first day on my Obstetrics rotation, and I was 
flustered, running late and feeling damp from the blistering 
Fresno heat. I stepped through the hospital doors and wan-
dered down a hallway replete with moans, yells and whim-
pers. I found the physician rounding room and glimpsed a 
white board divided into a grid, one line for each patient, 
rife with acronyms too arcane to decipher.
The chief resident saw me agape and assigned me my first 
patient, Ms. Lisa Valle1. I didn’t know what this assignment 
meant, but I understood enough to listen closely to the resi-
dent’s presentation. She quickly summarized the patient: ‘A 
19-year-old G1P0 at 22 weeks. Methamphetamine user with 
1 Name changed to protect identity of patient.
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After 2 weeks, Lisa’s condition had not changed. Each 
morning, at the end of her case discussion, a small pause 
ensued, as if to insulate such a hopeless patient from those 
more hopeful ones who came after. It was devastating to 
watch; my first ward as a someday doctor relegated to the 
corners of medicine, where treatment has yet to catch up 
with diagnosis.
Over the next few weeks, I visited Lisa frequently, watch-
ing her grow increasingly tired. One Wednesday, she was 
particularly alight, and when I asked after her good mood, 
she said she’d felt her baby moving. But when I asked the 
team about this hopeful turn, they were sceptical: the ultra-
sounds hadn’t shown any movement at all.
One morning, a classmate who had been on call the 
night before told me that Lisa’s temperature had risen and 
her blood pressure had dropped. Her baby had died and 
she had quickly turned septic. Her 25 weeks of pregnancy 
culminated in an emergent C-section. In the end, her baby 
had been doomed for weeks, a victim not of methamphet-
amine but a prematurely ruptured amniotic sac. As physi-
cians pulled her baby from her, they saw the child had only 
a single, sad eye placed squarely in the centre of its head.
In clinic weeks later, I heard a voice call my name from 
across the hall. I looked up and saw Lisa standing on a scale 
with a medical assistant. I walked over, and she spoke ani-
matedly about her time since leaving the hospital, with that 
same indefatigable cheerfulness I had encountered when we 
first met. She asked if I had heard what had happened to her 
child, and I said yes. I accompanied her into her appoint-
ment, and listened as the resident went through some com-
pulsory questions and an examination. Her drug history 
came up once, the resident dutifully asking whether she was 
still using meth. A cloud passed over Lisa’s face. I realized 
sadly that she wasn’t privy to the prominent inclusion of her 
drug history in her daily presentations and discharge sum-
mary. Her sunny disposition faltered slightly on a confu-
sion: is this what she was to people now?
In a medical system where patients have little agency, 
Lisa’s story highlights the power that health care provid-
ers wield. Lisa was no methamphetamine addict; her one-
time drug use was tangential to her medical care. Yet, weeks 
later, ensconced in the medical record, this history haunted 
her care. In each medical appointment now, Lisa would 
explain to a new provider that methamphetamine addiction, 
for all its horrors, was not her burden to bear. Lisa’s story 
should remind us that we are patients’ stewards in an opaque 
system, and our behaviour, even at its most automatic and 
seemingly inconsequential, can profoundly affect their 
health care for years to come.
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